A Novel Aerosol Foam Formulation of Calcipotriol and Betamethasone Has No Impact on HPA Axis and Calcium Homeostasis in Patients With Extensive Psoriasis Vulgaris

Abstract

BACKGROUND Fixed combination calcipotriol 50 µg/g (Cal; as hydrate) plus betamethasone 0.5 mg/g (as dipropionate; BD) has been formulated in an innovative aerosol foam. OBJECTIVE To assess systemic safety of Cal/BD aerosol foam. METHODS In a multicentre, single-arm, open-label, maximal-use systemic-exposure trial, adult patients with moderate to severe… (More)
DOI: 10.1177/1203475415597094

Topics

  • Presentations referencing similar topics